Skip to main content
NIH funding notice RFA-MH-15-800

Consortium on Biomarker and Outcome Measures of Social Impairment for Use in Clinical Trials in Autism Spectrum Disorder (U19)

Closed on December 10, 2014.

Posted
September 15, 2014
Close date
December 10, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,673,456 in first-year total cost, median $7,673,456.

Most frequent study sections

  1. Special Emphasis Panel[ZMH1 ERB-C (05)]1

Most frequent institutions

  1. YALE UNIVERSITY1
Competing awards under RFA-MH-15-800 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2015The Autism Biomarkers Consortium for Clinical Trials1U19MH108206-01MCPARTLAND, JAMES CHARLESYALE UNIVERSITY, CT$7,673,456ZMH1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.